Vinci Partners and Lazuli Partners completed the investment in Farmax.

Vinci Partners and Lazuli Partners, two private equity firms, completed the investment in Farmax, a cosmetics provider. Financial terms were not disclosed. "Since Vinci arrived, we have been experiencing a two-year growth cycle above what we had planned. And we understood that we needed new funding to accelerate the company's expansion," Ronaldo Ribeiro, Farmax CEO.